ZZJ-26160-02066
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 986 / WA
- Registered
- 2021-12-16
- Relationship
- Child or adolescent in my care
- Guardian
- 29V-19917-33381
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-22
Dose 1 — Pfizer-BioNTech
-
2021-12-14
Dose 2 — Pfizer-BioNTech
-
2021-12-16
Registered in v-safe
-
2021-12-16
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-19
- 2021-12-23
- 2021-12-30
-
2022-01-11
Survey response — day 28, dose 2, dependentMedDRA: Diarrhoea, Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Headache, sore throat, runny nose, diarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-01-21
- 2022-01-27
- 2022-03-15
- 2022-06-17
- 2022-12-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-22 | Pfizer-BioNTech | No |
| 2 | 2021-12-14 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 2, dependent
Symptoms: Headache, sore throat, runny nose, diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release